PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-117.41%
Both yoy net incomes decline, with EQT at -184.02%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.65%
Both reduce yoy D&A, with EQT at -14.75%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-300.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-34.78%
Negative yoy SBC while EQT is 1.67%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-2135.29%
Both reduce yoy usage, with EQT at -69.13%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1001.95%
AR is negative yoy while EQT is 176.46%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
141.16%
A yoy AP increase while EQT is negative at -70.71%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-2135.29%
Both reduce yoy usage, with EQT at -550.24%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
33766.67%
Well above EQT's 212.13%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-7.43%
Both yoy CFO lines are negative, with EQT at -12.79%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-7.13%
Negative yoy CapEx while EQT is 16.06%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1293.71%
Negative yoy acquisition while EQT stands at 110.51%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Growth well above EQT's 214.92%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-2.96%
We reduce yoy invests while EQT stands at 18.64%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-6900.00%
Both yoy lines negative, with EQT at -26.68%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
35.69%
We have some buyback growth while EQT is negative at -1575.37%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.